Exact Sciences (EXAS) Tops Q1 EPS by 9c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Exact Sciences (EXAS) PT Raised to $35 at Jefferies
April 28, 2017 10:40 AM EDTJefferies raised its price target on Exact Sciences (NASDAQ: EXAS) to $35.00 (from $25.00) while maintaining a Buy rating. Test volumes surged to ~100K units compared to Jefferies' ~88K expectations, reflecting a sharp acceleration from its run-rate over the past year.
EXAS raised its 2017... More
Exact Sciences (EXAS) PT Raised to $40 at Cowen; Guides Still Looks 'Very Conservative'
April 27, 2017 3:35 PM EDTCowen raised its price target on Exact Sciences (NASDAQ: EXAS) to $40.00 (from $30.00) while maintaining a Outperform rating following a solid start to the year.
Analyst Doug Schenkel noted revenue, new practice additions, and total orders were well ahead of expectations. In... More



